ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

VEGETABLE OILS-Inefficient Use of Imports

arthritic Opren. The drug was marketed by Eli Lilly, an American multinational, with much fanfare as the most revolutionary treatment for arthritic patients since aspirin in 1980. Soon afterwards it came to be known that the drug caused severe damage to the liver and the kidneys and resulted in extreme sensitivity to light. The company did not act on this information for two years by which time the drug had killed an estimated 93 people and injured 4,000. Most of these were elderly patients who are now using up their life savings to fight the case in British courts. UK's Committee on Safety of Medicines also chose to take a back-seat throughout this affair.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now


(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top